PF3D7_1126100 (ATG7) encodes an E1-like activating enzyme that operates at the apex of the ATG8 conjugation pathway in Plasmodium, driving ATG8 lipidation and membrane association during parasite development (PMID:39714137). In P. berghei, conditional depletion of ATG7 abolishes ATG8 lipidation and eliminates ATG8 localization to the apicoplast membrane, which in turn disrupts organelle biogenesis, impairs microneme exocytosis, and prevents merozoite formation during liver-stage metamorphosis; ATG7 itself resides in the parasite cytosol across blood, sporozoite, and liver stages (PMID:39714137, PMID:40395990). In P. falciparum, endogenously tagged PfATG7 is expressed as distinct protein species during erythrocytic stages, and conditional attenuation of its protein level produces a slow-growth phenotype, establishing that PfATG7 is required for normal blood-stage growth (PMID:23825614). Beyond its role as the E1-like activator upstream of ATG8 lipidation, no further catalytic mechanism or direct enzymatic characterization of PF3D7_1126100 has been established in the available corpus.